Atomo Diagnostics Limited (ASX:AT1) Share Price Remains Unchanged as Stock Trades Within Daily Range

Anjali Anand

13 August 2026 09:41 PM AEST

Atomo Diagnostics Limited (ASX:AT1) Share Price Remains Unchanged as Stock Trades Within Daily Range

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Key Highlights

Atomo Diagnostics Limited (ASX:AT1) shares remained unchanged at $0.018 during the latest trading session.
The stock traded within a daily range of $0.018 to $0.018.
Trading Volume reached 92,452 shares during the session.
Market capitalisation stood at $16.24M based on the latest provided figures.
The share price remained within its 52-week range of $0.016 to $0.048.

Overview

Atomo Diagnostics Limited (ASX:AT1) is listed on the Australian Securities Exchange and operates within the healthcare sector. The company is classified under the Health Care Equipment & Services industry group. This article provides an educational summary of the company’s latest available share price activity and market statistics based on the provided data.

The article covers available trading information, including share price movement, trading volume, market capitalisation, share structure and historical price range. It is intended to provide a factual overview of market activity and does not represent financial advice or a recommendation regarding the company’s shares.

Share Price Movement

Shares of Atomo Diagnostics Limited (ASX:AT1) closed at $0.018, remaining unchanged from the previous close of $0.018. The daily share price movement was recorded at 0.000% during the latest provided trading session.

During the session, the stock traded between an intraday high of $0.018 and an intraday low of $0.018. The unchanged day range indicates that the stock remained at the same price level throughout the reported trading period.

The stock’s 52-week trading range was recorded between $0.016 and $0.048. This range provides historical context regarding the highest and lowest prices reached by the stock over the previous 12-month period.

Trading Volume and Market Capitalisation

Atomo Diagnostics Limited recorded trading volume of 92,452 shares during the session. Trading volume represents the number of shares exchanged between buyers and sellers during a particular trading period and is commonly reviewed alongside share price movements to understand market participation.

The average volume for Atomo Diagnostics Limited was recorded at 1,243,070 shares. Comparing the latest trading volume with the stated average volume provides a reference point for the level of activity observed during the session.

The company’s Market Capitalisation was recorded at $16.24M based on the latest provided market data. Market capitalisation represents the total Market Value of a company’s Issued Shares and is calculated using the share price and shares on issue.

Share Information and Trading Details

Atomo Diagnostics Limited has 902,432,853 shares on issue, with its share structure classified as ordinary fully paid shares. The company was listed on the Australian Securities Exchange on 16 April 2020.

The bid and offer range was recorded between $0.017 and $0.019, representing the available quoted buying and selling levels during the trading session.

The stock’s daily trading range of $0.018 to $0.018 highlights the limited price movement recorded during the session. Such market statistics provide a snapshot of trading activity at a particular point in time.

Healthcare Sector Context

Atomo Diagnostics Limited is categorised within the healthcare sector, specifically under the Health Care Equipment & Services industry group. Companies within this category may operate across healthcare-related equipment, diagnostic products and associated services.

Individual share price movements can be influenced by company-specific developments, trading activity and broader market conditions. A single Trading session reflects short-term market activity and does not represent the complete performance history of a listed company.

Conclusion

In summary, Atomo Diagnostics Limited (ASX:AT1) shares remained unchanged at $0.018 during the latest reported session. The stock traded within a daily range of $0.018 to $0.018, with trading volume of 92,452 shares and a market capitalisation of $16.24M. The available market statistics, including the 52-week range, shares on issue and trading activity, provide an educational overview of the company’s latest market position based on the supplied information.

Frequently Asked Questions (FAQs)

FAQs

Q: What was the closing share price of Atomo Diagnostics Limited (ASX:AT1)?

A:Atomo Diagnostics Limited (ASX:AT1) closed at $0.018 based on the latest provided market data.

Q: Did AT1 shares record any movement during the session?

A:No. The share price remained unchanged at $0.018, with a daily change of 0.000%.

Q: What was the trading volume for Atomo Diagnostics Limited?

A:The trading volume for the session was 92,452 shares.

Q: What is the market capitalisation of Atomo Diagnostics Limited?

A:The company’s market capitalisation was recorded at $16.24M based on the provided figures.

Q: What was the 52-week trading range for ASX:AT1?

A:The 52-week trading range for Atomo Diagnostics Limited was between $0.016 and $0.048.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.